Barrier Therapeutics About
Barrier Therapeutics Barrier Therapeutics is a biopharmaceutical
company focused on the discovery, development and commercialization of a portfolio
of innovative pharmaceutical products to address major medical needs in the field
of dermatology. Barrier Therapeutics currentlyhas multiple product candidates
in clinical development, with four of these candidates in or entering Phase III
clinical trials. Pipeline
Chart Barrier Therapeutics More
on Barrier
Therapeutics Key
Statistics for Barrier Therapeutics
Zimycan™.
antifungal
agent Sebazole™.
antifungal
agent Liarozole oral
treatment for congenital ichthyosis Hyphanox™
fungal
infections, including vaginal candidiasis
Basic
Chart for Barrier Therapeutics